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ABSTRACT
The heritability of schizophrenia and most personality traits has been well established,
but the role of personality in susceptibility to schizophrenia remains uncertain. The aim
of this study was to test for an association between personality traits and Neurological
Soft Signs (NSS), a well-known biological marker of schizophrenia, in non-psychotic
relatives of patients with schizophrenia. For this purpose, we evaluated the NSS scale
and personality measured by the Temperament and Character inventory (TCI-R) in
three groups of subjects: 29 patients with schizophrenia, 24 unaffected relatives and
37 controls. The results showed that patients with schizophrenia were more asocial
(higher harm avoidance and lower reward dependence), more perseverative (higher
persistence), andmore schizotypal (lower self-directedness and cooperativeness, higher
self-transcendence). The unaffected relatives showed higher harm avoidance, lower
self-directedness and cooperativeness than the healthy controls. Higher NSS scores
and sub-scores were found in patients and non-psychotic relatives compared with the
controls. Among all the patients, total NSS scores were positively correlated with harm
avoidance but negatively correlated with novelty seeking and persistence. Total NSS
were also correlated with low scores on self-directedness and cooperativeness, which
are indicators of personality disorder. Our results show that susceptibility to NSS and
to schizophrenia are both related to individual differences in the temperament and
character features in non-psychotic relatives of patients with schizophrenia. High harm
avoidance, low persistence, low self-directedness and low cooperativeness contribute
to both the risk of NSS and schizophrenia. These findings highlight the value of using
both assessments to study high risk populations.
Subjects Psychiatry and Psychology
Keywords Schizophrenia, Neurological Soft Signs, Temperament and character, Vulnerability
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INTRODUCTION
Although the etiology of schizophrenia is still largely unknown, the genetic basis of this
disorder has been well established (Singh et al., 2014). The expression of susceptibility to
schizophrenia is incomplete and variable, as shown by the non-psychotic status of most
monozygotic co-twins of patients with schizophrenia, and the complex relationships of
different sets of genes with distinct sets of clinical features (Arnedo et al., 2014). Fortunately,
more subtle expressions of susceptibility to schizophrenia can be evaluated by studying
neuropsychological markers of susceptibility, such as personality traits and neurological
soft signs in the non-psychotic relatives of patients with schizophrenia (Smith et al., 2008).
Several studies have shown an association between schizophrenia and certain personality
traits; however, the nature of this relationship is not clarified (Silberschmidt & Sponheim,
2008; Smith et al., 2008). Among the different models for studying personality, Cloninger’s
model is the onewith themost explicit neurobiological basis (Cloninger, Svrakic & Przybeck,
1993). This model suggests that a person’s temperament is heritable and regulated by
neurotransmitters and brain circuits, which are involved in the pathophysiology of
schizophrenia. Both temperament and character traits are equally heritable (Gillespie
et al., 2003), but character is more shaped by sociocultural influences as it develops across a
lifespan (Josefsson et al., 2013a; Josefsson et al., 2013b). Temperament consists of individual
differences in behavioral conditioning of habits and skills, whereas character comprises of
individual differences based on goals and values, which involve higher cognitive processes
of semantic and autobiographical learning and memory (Silberschmidt & Sponheim, 2008;
Van Schuerbeek et al., 2014). Environmental factors do impact on both temperament
and character traits, however, these factors are more critical for the development of
character than temperament. By using this model, patients with schizophrenia have shown
a temperament and character profile that is distinct from the general population (Bora
& Veznedaroglu, 2007; Glatt et al., 2006; Kurs, Farkas & Ritsner, 2005; Ritsner & Susser,
2004). Specifically, people with schizophrenia and their non-psychotic relatives are higher
in the temperament of harm avoidance (i.e., more anxious and shy) and lower in the
temperament of reward dependence (i.e., more detached and cold emotionally), so
that they are more socially distant than controls. More recently, evidence has emerged
showing that the dimensions of character are heritable and may also influence the risk of
schizotypy (Silberschmidt & Sponheim, 2008). Specifically, people with schizophrenia and
their non-psychotic relatives have the schizotypal character profile of low self-directedness
(i.e., aimless and tending to blame others for their problems), low cooperativeness
(i.e., suspicious and lacking in empathy), and high self-transcendence (i.e., prone to
fantasy and magical thinking). Thus, Cloninger’s TCI provides a reliable way to quantify
personality traits related to susceptibility to the schizophrenia spectrum.
The association between personality and schizophrenia has been reinforced by several
studies that relate these personality traits with other abnormalities in schizophrenia.
For example, the correlation between some dimensions of temperament and changes
in monoaminergic activity has been postulated as the biological basis of schizophrenia
(Ebstein, 2006; Mitsuyasu et al., 2001). In addition, an interaction has been observed
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between polymorphisms of these two systems that predicts the scores on harm avoidance
(Benjamin et al., 2000).
Furthermore, several studies of schizophrenia have suggested an association between
personality traits and other candidate markers of vulnerability. Specifically, the presence
of schizotypal personality traits correlates with the presence of neurological soft signs
(NSS) in relatives of patients with schizophrenia (Mechri et al., 2009; Mechri et al., 2010).
Traditionally, NSS are defined as minor neurological abnormalities without a definite
localization in the brain, including several clinical manifestations related to simple motor
coordination, complex motor sequencing, sensory integration and disinhibition signs
(Chan & Gottesman, 2008). Alterations in motor coordination and integration of stimuli
are positively correlated with both the total scores and with the cognitive perceptive
component of scales measuring schizotypy (Chan et al., 2010; Kaczorowski, Barrantes-Vidal
& Kwapil, 2009). Thus, NSS have been suggested as markers of disease vulnerability, which
are present prior to the start of treatment and are independent of illness state (as well as
type of antipsychotic treatment) (Chan et al., 2010; Bombin, Arango & Buchanan, 2003),
and NSS are correlated with structural and functional brain abnormalities related to
schizophrenia (Mouchet-Mages et al., 2011; Zhao et al., 2014).
Interestingly, temperament and character features and NSS have been shown to
aggregate in the relatives of schizophrenia patients (Krebs et al., 2000; Andreasen et al.,
2005), supporting the view that both are likely to reflect genetic liability to schizophrenia.
In addition, the distribution of NSS in schizophrenia, and in first-degree relatives, is
consistent with the endophenotype criterion of familial association (Zhao et al., 2014).
However, belonging to the same family could act as a confounding factor because it
includes environmental influence and common genetic factors unrelated to the illness. In
this respect, no studies are available comparing both NSS and personality in patients with
schizophrenia and non-psychotic relatives.
The aim of this study was to investigate the association between personality traits,
neurological soft signs and vulnerability to schizophrenia. Firstly, to determine whether
personality traits could be vulnerability markers of schizophrenia, or if they are simply
associated with the disease, we compared personality traits and neurological soft signs
between patients, relatives and controls. Secondly, to establish whether those domains that
showed differences between groups were significantly associated with known markers of
disease vulnerability, correlations between personality traits and NSS were calculated for
the entire population.
MATERIALS AND METHODS
Subjects
A cross-sectional study was conducted on 29 patients with schizophrenia, 24 unaffected
relatives of patients and 37 controls. This study was conducted at the Neuropsychiatry
and Addictions Institute of the Parc de Salut Mar of Barcelona. The patients and the
non-psychotic relatives were recruited from outpatient services of the same institution.
Control subjects were recruited by announcements in the University and the Hospital. All
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participants lived in Spain for more than five years and were fluent Spanish speakers. The
non-psychotic relatives were not from the same families of the patients included in the
study, in order to avoid the effects of similar rearing that could induce potential similarities
in temperament and character between patients and siblings. Considering that the total
population was organized into three categories (patients, unaffected relatives and healthy
controls), the participants were matched by gender and age.
The exclusion criteria included the presence of a substance dependence disorder (with
the exception of nicotine dependence) according to DSM IV-TR (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition), the presence any other psychiatric disorder
of axis I or II of DSM IV-TR as well as the personal history of severe somatic or neurological
disorders. All subjects were between 25 and 50 years old and had an estimated IQ >80
measured by WAIS subscales (Digit, cubes, vocabulary, arithmetic, symbol search). The
patients were diagnosed with schizophrenia from the medical record and confirmed by
the Structured Clinical Interview for DSM Disorders. Unaffected relatives and healthy
controls were evaluated as well. All the patients had a disease duration between 5 and
15 years, were treated with atypical antipsychotics, had never received electroconvulsive
therapy and had been clinically stable for the last six months (all positive items of the
PANSS positive subscale scoring 4 or lower). The non-psychotic relatives were from the
same mother and father of a patient with a diagnosis of schizophrenia, according to DSM
IV-TR. Control subjects and their first and second degree relatives had to be free of any
axis I disorders. The study was approved by the ethics committee of the CEIC-Parc de Salut
Mar Hospital (2011/4141/I). All subjects gave informed written consent and were assured
of the confidentiality of the data being collected.
Experimental procedure
Basic socio-biographical data were collected from the medical history. This data included
years of education, socio-economic level, psychiatric and medical history, years from
disease onset, administered treatment and psychiatric history of first degree relatives.
Patients were clinically assessed using the Positive and Negative Syndrome Scale (PANSS)
(Peralta & Cuesta, 1994) and the overall functioning of the subjects was assessed using the
Global Adaptive Functioning (GAF) (Jones et al., 1995).
All subjects were assessed with the Spanish version of the Temperament and Character
Inventory (TCI-R) (Gutiérrez-Zotes et al., 0000) and theNeurological Soft Signs Scale (Krebs
et al., 2000). Temperament is comprised of novelty seeking (i.e., impulsive, exploratory),
harm avoidance (i.e., anxious, shy), reward dependence (i.e., sentimental, approval-
seeking) and persistence (i.e., determined, ambitious). Character is comprised of self-
directedness (i.e., responsible, purposeful), cooperativeness (i.e., helpful, empathic) and
self-transcendence (i.e., imaginative, self-forgetful). The TCI-R sub-scores for each of the
seven dimensions were calculated.
TheNSS scale is composed of 23 items, rated from 0 to 3, and regrouped in five consistent
factors: Motor coordination (hand dysrhythmia, finger opposition, fist edge–palm, foot
dysrhythmia, alternative movements: foot speed, alternative movements: hand speed,
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Table 1 Demographic characteristics in controls, non-psychotic relatives and patients with
schizophrenia.
Controls Non-psychotic
relatives
Patients p
n= 37 n= 24 n= 29
Mean Age (years)± SD 36.78± 7.61 40.92± 10.32 37.97± 7.13 0.165
Gender (M/F) 17/20 11/13 16/13 0.713
Mean years of education (years)± SD 12.89± 1.76 11.50± 2.65 10.00± 2.80 <0.05∗
standing heel-to-toe), Motor integration (Romberg, apraxia, tandem walk, finger-to-
nose, gait, tongue protrusion), Sensory integration (stereognosia, hand–face, constructive
apraxia, graphesthesia, right-left recognition),Quality of lateralization (right-left confusion,
lateral preference, right-left asymmetry) and Involuntarymovements (abnormalmovement
and posture, mirror movements).
The NSS total score and sub-scores for each of the factors were calculated. Two assessors
(LG and FP) were trained to perform the neurological assessment. The inter-rater reliability
of the assessment of NSS was established by the two assessors and jointly examined 20
independent subjects. The intra-class correlation coefficient (SPSS: two way Mixed Effect
Model, confidence interval = 95%) was 0.90 [0.77–0.95].
Statistical analysis
First, univariate analyses of the sociodemographic data were performed. Differences in age
and years of education were determined with the Analysis of Variance (ANOVA), and the
chi square test was applied for gender differences. As there were statistical differences in
years of education, it was added as a covariate in the rest of the analyses.
Temperament, character and NSS scores were analyzed with the Levene test. Then,
to study differences between groups, and depending on the results on Levene tests, the
analysis was performed with ANOVAs followed by the Bonferroni post-hoc test or a
Kruskall–Wallis test followed by Mann–Whitney U test, adding years of education as a
covariate. Pearson correlations were performed using the entire population between the
total NSS scores and sub-scores for each temperament and character domains, adding
years of education as a covariate. Accepting an alpha risk of 0.05 and a beta risk of 0.2
in a two-sided test, 23 subjects are necessary in every group to recognize as statistically
significant a difference greater than or equal to 1 unit. The common standard deviation is
assumed to be 1.2. It has been anticipated a drop-out rate of 0%.
RESULTS
Demographic characteristics
No significant differences between groupswere observed in terms of age or gender; although
patients with schizophrenia and non-psychotic relatives showed significantly less years of
education than controls (Table 1).
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Table 2 Temperament and character scores in controls, non-psychotic relatives and patients with schizophrenia.
Controls Non-psychotic
relatives
Patients F p
n= 37 n= 24 n= 29
Harm avoidance
(mean± SEM)
86.18± 1.85 99.38± 4.49 109.21± 2.97 13.10 <0.01∗
Reward dependence
(mean± SEM)
109.36± 2.03 101.38± 3.13 99.79± 3.66 3.15 <0.05∗
Novelty seeking
(mean± SEM)
102.39± 1.55 102.81± 2.88 97.7± 2.43 1.29 0.27Temperament
Persistence
(mean± SEM)
113.91± 2.63 103.14± 4.75 100.58± 3.50 3.83 <0.05∗
Self-directedness
(mean± SEM)
159.62± 2.87 141.14± 4.64 134.67± 4.40 10.11 <0.01∗
Cooperativeness
(mean± SEM)
147.17± 2.24 137.05± 2.57 133.12± 3.86 5.59 <0.05∗
Character
Self-Transcendence
(mean± SEM)
54.30± 2.56 58.76± 2.82 66.25± 3.99 3.63 <0.05∗
Temperament scores (TCI-R)
Table 2 shows the scores obtained for each temperament dimension in controls, non-
psychotic relatives and patients. Harm Avoidance scores were significantly different
between the groups (F(2,88) = 13.10, p< 0.001) (Fig. 1). Subsequent post-hoc analysis
revealed that patients with schizophrenia and non-psychotic relatives obtained significantly
higher scores on harm avoidance than controls, and patients showed significantly higher
scores than relatives (Fig. 1). In addition, significant differences between the groups were
observed in reward dependence (F(2,88) = 3.15, p< 0.05) and persistence (F(2,88) =
3.83, p< 0.05) scores. The post-hoc test revealed that patients obtained significantly lower
reward dependence scores than controls and both patients and non-psychotic relatives
had lower persistence scores than controls. No significant differences between groups were
observed for novelty seeking scores (Fig. 1).
Character scores (TCI-R)
Table 2 shows the scores obtained for each character dimension in controls, non-psychotic
relatives and patients. Significant differences between groups were observed in self-
directedness, cooperativeness and self-transcendence scores. A subsequent subgroups
analysis revealed that both patients and relatives obtained significantly lower scores on
self-directedness and cooperativeness than the controls (Fig. 2). In addition, no significant
differences were observed in self-directedness or cooperativeness scores between patients
and relatives. Finally, significantly higher self-transcendence scores were observed in
patients with schizophrenia than in the controls (Fig. 2).
Neurological soft signs scores
Significant differences between groups were observed for the total NSS scores (F(2,88)
= 41.98, p< 0.01). A subsequent post-hoc analysis revealed significantly higher NSS
scores in both non-psychotic relatives and patients, compared with the control subjects.
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Figure 1 Temperament scores in controls, non-psychotic relatives and patients with schizophrenia.
Harm avoidance (A), reward dependence (B), persistence (C) and novelty seeking (D) scores. The data are
represented as mean+ SD. ∗p< 0.05 vs. controls; #p< 0.05 vs. relatives.
In addition, patients showed higher total NSS scores than non-psychotic relatives (Fig. 3).
Scores obtained in each NSS domain for the three groups are shown in Table 3. Significant
differences between groups were observed for each of the NSS sub-scores. Post-hoc analyses
revealed significantly higher scores in motor coordination and involuntary movements in
patients and relatives, as compared with the controls. In addition, patients showed higher
scores than relatives in both of these NSS sub-scores. With respect to motor integration
and quality of lateralization, patients and relatives also showed higher scores than control
subjects, while no significant differences were observed between patients and relatives.
For sensory integration, higher scores were observed only in patients compared with the
control group (Fig. 3).
Correlations between NSS and TCI-R scores
Table 4 shows the Pearson coefficients obtained for correlations between NSS scores
and temperament and character scores for the entire population studied. In terms
of temperament, total NSS scores were positively correlated with harm avoidance,
while a negative correlation was observed between total NSS, novelty seeking and
persistence scores. When each temperament dimension was analyzed separately, harm
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Figure 2 Character scores in controls, non-psychotic relatives and patients with schizophrenia. Self-
directedness (A), cooperativeness (B) and self-transcendence (C) scores. The data are represented as mean
+ SD. ∗p< 0.05 vs. controls.
Table 3 NSS scores in controls, non-psychotic relatives and patients with schizophrenia.
Neurological soft sign scores Controls Non-psychotic relatives Patients F P
n= 37 n= 24 n= 29
Motor coordination (mean± SEM) 0.71± 0.18 1.65± 0.34 3.13± 0.37 15.32 <0.001∗
Sensory integration (mean± SEM) 1.13± 0.15 1.65± 0.18 2.57± 0.38 6.31 <0.001∗
Motor integration (mean± SEM) 1.32± 0.11 4.85± 0.33 4.52± 0.33 36.29 <0.001∗
Quality of lateralization (mean± SEM) 0.29± 0.09 0.95± 0.34 0.73± 0.17 4.20 <0.01∗
Involuntary movement (mean± SEM) 0.94± 0.15 1.25± 0.18 2.78± 0.40 13.03 <0.001∗
avoidance scores correlated significantly with sensory integration, motor coordination
and motor integration scores. For persistence, significant negative correlations were
observed with motor coordination, sensory integration, motor integration and involuntary
movements. Finally, a positive correlation was observed between reward dependence
and involuntary movements. Novelty seeking scores were negatively correlated with
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Figure 3 Total neurological soft signs (NSS) scores in controls, non-psychotic relatives and patients
with schizophrenia. The data are represented as mean+ SD. ∗p< 0.05 vs. controls; #p< 0.05 vs. relatives.
Table 4 Correlations coefficients between NSS and temperament features and between NSS and character traits in controls, non-psychotic
relatives and patients with schizophrenia.
Total NSS Sensory integration Motor coordination Motor integration Quality lateralization Involuntary
movement
Harm avoidance 0.95∗ 0.38∗ 0.35∗∗ 0.48∗ 0.03 0.16
Reward dependence −0.12 −0.12 −0.16 −0.15 0.10 0.25∗
Novelty seeking −0.40∗ −0.84∗ −0.22 −0.15 −0.29∗ −0.15
Persistence −0.95∗ −0.43∗ 0.29* −0.43∗ −0.08 −0.40∗
Self-directedness −0.80∗ −0.18 −0.39∗ −0.40∗ 0.03 −0.08
Cooperativeness −0.55∗ −0.22∗ −0.32∗ −0.23∗ −0.01 −0.13
Self-transcendence 0.19 0.07 0.27∗ 0.20 −0.01 −0.01
sensory integration. With regards to character, total NSS scores were negatively correlated
with self-directedness and cooperativeness. For the individual character domains,
self-directedness was negatively correlated with motor coordination and motor integration
scores, while cooperativeness was negatively correlated with sensory integration, motor
integration and motor coordination scores. No significant correlations were observed
between self-transcendence and total NSS scores, although a positive correlation was
present with motor coordination.
DISCUSSION
The major finding in this study was that patients with schizophrenia and non-psychotic
relatives display a unique profile of temperament and character that correlates with
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alterations in NSS. Comparing personality traits and NSS between groups, both patients
with schizophrenia andnon-psychotic relatives obtained significantly higher scores onharm
avoidance than controls, and patients showed significantly higher scores than relatives.
Also, patients and non-psychotic relatives had lower persistence, self-directedness, and
cooperativeness scores than controls. In addition, no significant differences were observed
in self-directedness or cooperativeness scores between patients and relatives. Finally,
significantly higher self-transcendence scores were observed in patients with schizophrenia,
compared to controls.
Our results reveal an association between these hypothesized vulnerability markers,
as temperament (especially harm avoidance, reward dependence and persistence) and
character (especially self-directedness and cooperativeness) correlated with the presence of
NSS in the entire sample.
Studies in non-psychotic relatives have been essential to uncover new vulnerability
biomarkers of schizophrenia. In this sense, several studies have provided evidence showing
that particular personality features could be considered as possible schizophrenia-related
endophenotypes (Smith et al., 2008). In this study, it was found that non-psychotic relatives
had significantly higher harm avoidance scores comparedwith the controls, but lower scores
than patients with schizophrenia. In agreement with our data, Smith et al. (2008) found
higher harm avoidance scores in siblings of patients with schizophrenia than in controls
subjects, and another study reported that siblings are positioned between controls and
patients with schizophrenia, in terms of temperament profile (Calvó de Padilla et al., 2006).
In contrast, Bora & Veznedaroglu (2007) did not find differences in temperament between
relatives of schizophrenic patients and the controls, although they did observe differences
in harm avoidance between controls and relatives with high schizotypy. Together, these
studies support the idea that high levels of harm avoidance may be associated with genetic
vulnerability to schizophrenia, which, in turn, will interact with environmental and
neurobiological influences to determine the expression of the disease. According to Kim
et al. (2011) and Hansenne et al. (2003), harm avoidance has been associated with D2/3
receptor availability in the associative and sensorimotor subdivisions of the striatum and
high Mismatch Negativity and hypervigilant fear perception, suggesting abnormal sensory
gating of aversive stimuli as a vulnerability variable in schizophrenia. Furthermore, a locus
on chromosome 8p21 associated to schizophrenia showed a linkage to harm avoidance
(Zohar et al., 2003).
With regards to character, it was found that, similar to patients; non-psychotic relatives
had significantly lower self-directedness and cooperativeness scores when compared to
controls. Other studies have reported lower levels of self-directedness and cooperativeness
in siblings with high schizotypy as compared to controls, and high levels were observed in
siblings with low schizotypy (Bora & Veznedaroglu, 2007). One important aspect of the data
in this study is that even though the non-psychotic relatives that participated in this study
did not have familial ties to the patients with schizophrenia, they showed similar low levels
of self-directedness and cooperativeness. It is well known that character is influenced more
by environmental factors than temperament (Josefsson et al., 2013a; Josefsson et al., 2013b).
However, the data in this study agrees with other studies, such as Gillespie et al., (2003);
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Josefsson et al., (2013a); Josefsson et al., (2013b), showing that character may also have a
genetic component. Self-transcendence was higher in patients than in the controls subject,
but not in relatives. These results are in agreement with other studies reporting elevated
self-transcendence in patients (Glatt et al., 2006; Smith et al., 2008). In contrast, Calvó de
Padilla et al. (2006) found lower self-transcendence and cooperativeness in the relatives of
patients with schizophrenia with respect to the controls. The discrepancies between studies
could be due to the fact that the population used in the Calvo and Padilla study was an
indigenous community living in a rural environment and not in an urban environment.
In accordance with previous studies, we found lower levels of persistence and reward
dependence only in patients with schizophrenia as compared to controls. These findings
endorse the hypothesis stating that high harm avoidance, low persistence and low reward
dependence constitutes a temperament profile leading to social detachment, perseveration
and schizotypy, when combined with a disorganized character profile that impairs
emotional regulation (Smith et al., 2008; Bora & Veznedaroglu, 2007).
As reported previously in patients with schizophrenia (Bombin, Arango & Buchanan,
2003; Chen et al., 2005; Aksoy-Poyraz et al., 2011) and in non-psychotic relatives (Gourion
et al., 2004;Mechri et al., 2010), we found higher NSS in both groups as compared with the
controls, confirming the hypothesis that NSS is a vulnerability marker for schizophrenia.
In addition, these results agree with the idea that NSS segregate with the illness and
may be a valid and useful endophenotype (Chan et al., 2010). The association between
personality characteristics and NSS has been studied separately in siblings, or in patients
with schizophrenia, but there are no prior studies correlating NSS with personality traits
in patients with schizophrenia, non-psychotic relatives and controls. Our correlational
analysis, including all three groups, showed that subjects with higher NSS scores exhibited
higher harm-avoidance and persistence scores, while they exhibited lower self-directness
and cooperativeness. Two related studies have evaluated the association between NSS
and schizotypal personality traits with contradictory results. Thus, Mechri et al. (2010),
using the Schizotypal Personality Questionnaire (SPQ), showed that the overall NSS score
was correlated with the presence of schizotypal traits in both non-psychotic siblings and
controls, while no association was found between NSS and schizotypal dimensions in
relatives of patients with schizophrenia, when the SPQ test was used (Bollini et al., 2007).
The differences observed between these two studies, as well as the present work, could be
due to the fact that they used a personality assessment tool based on outdated DSM III
criteria. In this respect, one of the strengths of this study is the use of the TCI-R scale, which
is a comprehensive personality questionnaire that has been extensively validated in clinical
practice and research (Fassino et al., 2013; Fresán et al., 2015). One of the advantages of the
TCI-R is that it explores normal and pathological personalities in subjects with mental
disorders and also in the general population (Cloninger et al., 2012; Josefsson et al., 2011;
De Fruyt et al., 2006). Another advantage is that temperament and character domains
have been associated with structural and functional changes in the brain (Laricchiuta et al.,
2014; Lei et al., 2014; Tuominen et al., 2013), and have been related to specific chromosomal
regions (Serretti et al., 2008; Zohar et al., 2003) supporting the neurobiological substrate for
this personality model (Yang et al., 2015). Another strength of the study is that the relatives
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of patients with schizophrenia had no familial ties to the patients used, thus decreasing the
possibility that similar rearing would confound the results.
Finally, several limitations of the study are acknowledged. The first is the small sample
size used, even though the TCI-R scores and NSS scores were similar to those reported
in larger samples in the literature (Smith et al., 2008; Mechri et al., 2010). The second
limitation is the use of an estimate of IQ values as a selection criterion, but not as a
covariate in the analysis. This issue may have been a potential confounding factor, since
IQ has been previously associated with personality and with NSS.
In conclusion, these results showed that patients with schizophrenia were more asocial
(higher harm avoidance and lower reward dependence), more perseverative (higher
persistence) and more schizotypal (lower self-directedness and cooperativeness, higher
self-transcendence). In the group analysis, we found significant changes in personality
traits in relatives of patients with schizophrenia. Indeed, non-psychotic relatives showed
higher harm avoidance, lower self-directness and lower cooperativeness when compared to
control subjects. Interestingly, all three items were correlated with total NSS scores. Thus,
a positive correlation was observed between higher harm avoidance and total NSS, and
negative correlationswere found between lower self-directedness and lower cooperativeness
with total NSS. These findings lend support to the idea that such personality traits could
be potential vulnerability markers for schizophrenia. These vulnerability markers are likely
to be useful tools in the prospective studies of high-risk populations.
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